Te Ahumairangi Investment Management Ltd bought a new position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 13,092 shares of the company’s stock, valued at approximately $5,104,000.
Several other hedge funds have also bought and sold shares of the stock. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare in the 3rd quarter worth $26,000. MidFirst Bank bought a new stake in HCA Healthcare during the second quarter worth about $28,000. Clearstead Trust LLC bought a new position in HCA Healthcare during the second quarter valued at approximately $29,000. Ares Financial Consulting LLC purchased a new position in HCA Healthcare in the 4th quarter worth $31,000. Finally, Cedar Mountain Advisors LLC purchased a new position in shares of HCA Healthcare in the first quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on HCA. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research note on Tuesday, July 7th. JPMorgan Chase & Co. decreased their target price on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a report on Thursday. Robert W. Baird decreased their price target on shares of HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Finally, TD Cowen reduced their target price on HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $462.64.
HCA Healthcare Stock Down 0.0%
Shares of HCA stock opened at $429.08 on Monday. The company has a 50 day moving average price of $397.16 and a 200-day moving average price of $443.77. The firm has a market capitalization of $92.90 billion, a PE ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same period last year, the firm earned $6.84 earnings per share. The company’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts anticipate that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be given a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Further Reading
- Five stocks we like better than HCA Healthcare
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
